EUVIMEDEUVIMED entdecken
Crossref

Excess Out-of-Pocket Costs of Insulin Under the Inflation Reduction Act

Michael Fang, Chen Dun, Caitlin W. Hicks, Elizabeth Selvin, Jung-Im Shin, Mariana P. Socal

Diabetes Care · 20.11.2026

DOI: 10.2337/dc26-2122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes Care, online erschienen am 20.11.2026. Verfasst von Michael Fang und 5 weiteren Autor:innen. Gefördert von: National Institute of Diabetes and Digestive and Kidney Diseases, National Heart, Lung, and Blood Institute, Arnold Ventures.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Heart, Lung, and Blood Institute
  • Arnold Ventures
  • American Heart Association

Zitieren

APA

Fang, M., Dun, C., Hicks, C. W., Selvin, E., Shin, J., & Socal, M. P. (2026). Excess Out-of-Pocket Costs of Insulin Under the Inflation Reduction Act. Diabetes Care. https://doi.org/10.2337/dc26-2122

Vancouver

Fang M, Dun C, Hicks CW, Selvin E, Shin J, Socal MP. Excess Out-of-Pocket Costs of Insulin Under the Inflation Reduction Act. Diabetes Care. 2026. doi:10.2337/dc26-2122

BibTeX
@article{Fang2026,
  author = {Fang, Michael and Dun, Chen and Hicks, Caitlin W. and Selvin, Elizabeth and Shin, Jung-Im and Socal, Mariana P.},
  title = {Excess Out-of-Pocket Costs of Insulin Under the Inflation Reduction Act},
  journal = {Diabetes Care},
  year = {2026},
  doi = {10.2337/dc26-2122}
}
Kostenlos starten →